About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat ...

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an ...

A patient symptoms of functional and cognitive decline, dyskinesia and depression surprisingly resolve after a suicide attempt.

A 64 years old Caucasian female patient, education: 6 years, with history of hypothyroidism, depression, anxiety disorder and extrapyramidal symptoms was examined at our Memory and Dementia ...

Bayer AG BAYRY announced that the FDA has approved a label expansion of kidney disease drug Kerendia (finerenone). The ...

Titusville: Johnson & Johnson has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug ...

Johnson & Johnson submits sNDA to US FDA for Caplyta for prevention of relapse in schizophrenia: Titusville, New Jersey Wednesday, July 9, 2025, 14:00 Hrs [IST] Johnson & Johnson ...

NMRA-861 has demonstrated a potentially best-in-class pharmacological profile and robust activity in preclinical efficacy models. NMRA-861 was safe and well-tolerated in pre-clinical toxicology ...

NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile No convulsions observed in pre-clinical studies conducted in multiple species, including rabbit ...

Fintel reports that on July 9, 2025, Wedbush initiated coverage of Cartesian Therapeutics (NasdaqGM:RNAC) with a Outperform ...

Drake White Musician Drake White will perform Thursday, Sept. 11 at the University of Alabama at Birmingham ’s Alys Stephens ...